US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Design Therapeutics, Inc.

4.80

-0.0600-1.23%

Volume:172.40K

Turnover:802.15K

Market Cap:272.46M

PE:-5.48

High:4.94

Open:4.86

Low:4.27

Close:4.86

Loading ...

Overview Company News Filings

Design Therapeutics Says Eye Drops for Fuchs Endothelial Corneal Dystrophy 'Well-Tolerated'

MT Newswires Live

Design Therapeutics Announces Favorable Phase 1 Data for DT-168 Supporting Advancement Into Phase 2 Biomarker Trial for Patients With Fuchs Endothelial Corneal Dystrophy

THOMSON REUTERS

Design Therapeutics Announces Favorable Phase 1 Data for DT-168 Supporting Advancement into Phase 2 Biomarker Trial for Patients with Fuchs Endothelial Corneal Dystrophy

Design Therapeutics to Present Phase 1 Data for Fuchs Endothelial Corneal Dystrophy Program at Eyecelerator @ Park City 2025

Design Therapeutics Names Chris Storgard as Chief Medical Officer

MT Newswires Live

Press Release: Design Therapeutics Appoints Veteran Industry Executive Chris Storgard, M.D., as Chief Medical Officer

Bright Peak Therapeutics Appoints John Schmid to its Board of Directors

Top Premarket Gainers

MT Newswires Live

RBC Raises Price Target on Design Therapeutics to $5 From $4, Keeps Sector Perform, Speculative Risk

MT Newswires Live

Design Therapeutics Q4 2024 GAAP EPS $(0.24) Beats $(0.28) Estimate

BRIEF-Design Therapeutics Q4 Basic EPS USD -0.24

Design Therapeutics Q4 Net Income USD -13.651 Million

THOMSON REUTERS

Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Fourth Quarter and Full Year 2024 Financial Results

Design Therapeutics to Participate in Leerink’s Global Healthcare Conference

3 Promising US Penny Stocks With Market Caps Under $900M

Simply Wall St.

Top Premarket Decliners

MT Newswires Live

Investors Look to Reverse Last Week's Slide as US Futures Mixed Monday Pre-Bell

MT Newswires Live

Design Therapeutics to Participate in Multiple Upcoming Investor Conferences

Cautious Optimism for Design Therapeutics Amid Promising Developments and Financial Challenges

Design Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/DSGN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DSGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DSGN\",,,,,undefined,":{"symbol":"DSGN","market":"US","secType":"STK","nameCN":"Design Therapeutics, Inc.","latestPrice":4.8,"timestamp":1746127403548,"preClose":4.86,"halted":0,"volume":172396,"delay":0,"floatShares":25303308,"shares":56762678,"eps":-0.876312,"marketStatus":"Trading","change":-0.06,"latestTime":"05-01 15:24:14 EDT","open":4.86,"high":4.94,"low":4.2654,"amount":802152.8127339999,"amplitude":0.138807,"askPrice":4.81,"askSize":280,"bidPrice":4.79,"bidSize":160,"shortable":0,"etf":0,"ttmEps":-0.876312,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746129600000},"marketStatusCode":2,"adr":0,"listingDate":1616731200000,"exchange":"NASDAQ","adjPreClose":4.86,"preHourTrading":{"tag":"盘前","latestPrice":4.96,"preClose":4.86,"latestTime":"09:27 EDT","volume":42,"amount":215.12997660000002,"timestamp":1746106070025},"postHourTrading":{"tag":"盘后","latestPrice":4.31,"preClose":4.86,"latestTime":"17:35 EDT","volume":2278,"amount":10862.045,"timestamp":1746048948454},"volumeRatio":1.191397,"impliedVol":1.1123,"impliedVolPercentile":0.484},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DSGN\",,,,,undefined,":{"symbol":"DSGN","floatShares":25303308,"roa":"-14.39%","roe":"-19.08%","lyrEps":-0.876312,"volumeRatio":1.191397,"shares":56762678,"dividePrice":0,"high":4.94,"amplitude":0.138807,"preClose":4.86,"low":4.2654,"week52Low":2.6,"pbRate":"1.13","week52High":7.77,"institutionHeld":0,"latestPrice":4.8,"committee":-0.272727,"eps":-0.876312,"divideRate":0,"volume":172396,"delay":0,"ttmEps":-0.876312,"open":4.86,"prevYearClose":6.17,"prevWeekClose":3.88,"prevMonthClose":4.86,"prevQuarterClose":3.86,"fiveDayClose":4.24,"twentyDayClose":3.79,"sixtyDayClose":4.84},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DSGN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532888223","title":"Design Therapeutics Says Eye Drops for Fuchs Endothelial Corneal Dystrophy 'Well-Tolerated'","url":"https://stock-news.laohu8.com/highlight/detail?id=2532888223","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532888223?lang=en_us&edition=fundamental","pubTime":"2025-05-02 00:29","pubTimestamp":1746116981,"startTime":"0","endTime":"0","summary":"Design Therapeutics  said Thursday its experimental DT-168 eye drops to potentially treat Fuchs endothelial corneal dystrophy were well-tolerated in a phase 1 trial.The company said no serious side effects nor eye-related issues were reported. No treatment was discontinued due to adverse side effects, Design added.The company said it expects to begin a phase 2 biomarker trial in patients with Fuchs endothelial corneal dystrophy in H2, with results anticipated in 2026.The study will enroll FECD patients scheduled for corneal transplant surgery, the company added.Shares of the company were down 3.3% in recent trading.Price: 4.70, Change: -0.16, Percent Change: -3.29","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","BK4007","BK4139","BK4505","DSGN","LENZ"],"gpt_icon":0},{"id":"2532107931","title":"Design Therapeutics Announces Favorable Phase 1 Data for DT-168 Supporting Advancement Into Phase 2 Biomarker Trial for Patients With Fuchs Endothelial Corneal Dystrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2532107931","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532107931?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:00","pubTimestamp":1746100800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nTUA5BLKXS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","DSGN","BK4505","BK4139"],"gpt_icon":0},{"id":"2532018074","title":"Design Therapeutics Announces Favorable Phase 1 Data for DT-168 Supporting Advancement into Phase 2 Biomarker Trial for Patients with Fuchs Endothelial Corneal Dystrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2532018074","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532018074?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:00","pubTimestamp":1746100800,"startTime":"0","endTime":"0","summary":"Phase 2 biomarker trial in FECD patients anticipated to begin in the second half of 2025. CARLSBAD, Calif., May 01, 2025  -- Design Therapeutics, Inc. , a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced favorable data from a Phase 1 single- and multiple-ascending dose  trial of DT-168 in healthy volunteers, which will be presented on May 2, 2025 at Eyecelerator @ Park City 2025, an event backed by the American Academy of Ophthalmology highlighting industry advancements and innovative new products disrupting eye care.Based on these findings, Design plans to conduct a Phase 2 biomarker trial of DT-168 to evaluate safety, tolerability, and corneal endothelium biomarkers in patients with FECD. The trial will enroll FECD patients with the TCF4 mutation who are sc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/design-therapeutics-announces-favorable-phase-120000674.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4181","BK4539","BK4505","BK4218","PK","DSGN","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2529833720","title":"Design Therapeutics to Present Phase 1 Data for Fuchs Endothelial Corneal Dystrophy Program at Eyecelerator @ Park City 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529833720","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529833720?lang=en_us&edition=fundamental","pubTime":"2025-04-22 04:01","pubTimestamp":1745265660,"startTime":"0","endTime":"0","summary":"CARLSBAD, Calif., April 21, 2025  -- Design Therapeutics, Inc. , a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that it will present an update on the progress of its DT-168 program for Fuchs endothelial corneal dystrophy  at Eyecelerator @ Park City 2025 on Friday, May 2, 2025, at 1:30 p.m. MT in Park City, UT. The presentation will include safety findings from the Phase 1 single- and multiple-ascending dose trial of DT-168 in healthy adult volunteers and plans for Phase 2 clinical development in FECD patients.DT-168 is a GeneTAC small molecule, formulated as an eye drop, that is designed to selectively target the CTG repeat expansion in the TCF4 gene and reduce the expression of the mutant gene product that causes corneal endothelial cell dysfunction leading to FECD.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/design-therapeutics-present-phase-1-200100583.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","LENZ","BK4139","BK4505","CHCO","DSGN","BK4211","BK4007"],"gpt_icon":0},{"id":"2528749488","title":"Design Therapeutics Names Chris Storgard as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2528749488","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528749488?lang=en_us&edition=fundamental","pubTime":"2025-04-17 22:27","pubTimestamp":1744900048,"startTime":"0","endTime":"0","summary":"Design Therapeutics  appointed Chris Storgard as chief medical officer.Storgard was most recently the chief medical officer at ADARx Pharmaceuticals, Design Therapeutics said Thursday in a statement.Shares of the company rose 2.7% in recent Thursday trading.Price: 3.47, Change: +0.09, Percent Change: +2.66","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4505","BK4139","LENZ","BK4007","BK4539","DSGN"],"gpt_icon":0},{"id":"2528716513","title":"Press Release: Design Therapeutics Appoints Veteran Industry Executive Chris Storgard, M.D., as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2528716513","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528716513?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:00","pubTimestamp":1744891200,"startTime":"0","endTime":"0","summary":"CARLSBAD, Calif., April 17, 2025  -- Design Therapeutics, Inc. , a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced the appointment of Chris M. Storgard, M.D., as Chief Medical Officer . Dr. Storgard brings over two decades of leadership and hands-on drug development experience, having successfully advanced multiple assets from preclinical stages through global regulatory approvals.\"I am excited to join Design and be part of a passionate team dedicated to transforming the lives of patients with severe genetic diseases,\" said Dr. Storgard. \"The company's innovative approach with GeneTAC small molecules represents a compelling opportunity to deliver meaningful clinical advancements across a range of monogenetic disorders, starting with DT-216P2 for Friedreich ataxia. I look forward to applying my experience to further drive clinical and regulatory execution and to realize the full po","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","DSGN","R","BK4022","BK4139","BK4539","LENZ","BK4007","BK4505"],"gpt_icon":0},{"id":"2528337790","title":"Bright Peak Therapeutics Appoints John Schmid to its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2528337790","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528337790?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:00","pubTimestamp":1744887600,"startTime":"0","endTime":"0","summary":"SAN DIEGO and BASEL, Switzerland , April 17, 2025  -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors.“It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak Therapeutics. “John brings decades of experience and an extensive track record of success in the biotech sector. His strategic insights and financial expertise will be instrumental as we advance our clinical pipeline and scale Bright Peak for long-term success.”Bright Peak Therapeutics is a clinical-stage biotechnology company pioneering multifunctional immunotherapies to treat cancer. Leveraging innovative protein engineering and a proprietary chemical conjugation platform, Bright Peak is building a robust pipeline of first-in-class multifunctional molecules. Its lead pro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bright-peak-therapeutics-appoints-john-110000857.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","XERS","SKIS","LENZ","DSGN","ANAB","BK4139"],"gpt_icon":0},{"id":"2524461776","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2524461776","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524461776?lang=en_us&edition=fundamental","pubTime":"2025-04-02 19:37","pubTimestamp":1743593860,"startTime":"0","endTime":"0","summary":"SHF Holdings  shares surged 58% pre-bell Wednesday following a 2.3% loss in the previous session.Design Therapeutics  shares jumped 52%, reversing Tuesday's loss.Sunshine Biopharma  shares advanced 55%, a day after the company reported higher annual revenue for its fiscal 2024.TTEC Holdings  shares were up 28% in recent premarket activity Wednesday. The company said late Tuesday that its special board committee concluded its review of Chief Executive Kenneth Tuchman's unsolicited buyout offer for TTEC and suggested to engage with him for a definitive deal proposal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4164","TTEC","SHFS","BK4539","SBFM","BK4106","BK4505","BK4139","DSGN","BK4226"],"gpt_icon":0},{"id":"2518719112","title":"RBC Raises Price Target on Design Therapeutics to $5 From $4, Keeps Sector Perform, Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2518719112","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518719112?lang=en_us&edition=fundamental","pubTime":"2025-03-11 18:22","pubTimestamp":1741688548,"startTime":"0","endTime":"0","summary":"RBC Raises Price Target on Design Therapeutics to $5 From $4, Keeps Sector Perform, Speculative Risk","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DSGN","LENZ"],"gpt_icon":0},{"id":"2518244226","title":"Design Therapeutics Q4 2024 GAAP EPS $(0.24) Beats $(0.28) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2518244226","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518244226?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:10","pubTimestamp":1741605026,"startTime":"0","endTime":"0","summary":"Design Therapeutics (NASDAQ:DSGN) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.28) by 14.29 percent. This is a 14.29 percent decrease over losses of $(0.21) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44215807/design-therapeutics-q4-2024-gaap-eps-0-24-beats-0-28-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSGN","LENZ"],"gpt_icon":0},{"id":"2518244962","title":"BRIEF-Design Therapeutics Q4 Basic EPS USD -0.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2518244962","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518244962?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:08","pubTimestamp":1741604894,"startTime":"0","endTime":"0","summary":"BRIEF-Design Therapeutics Q4 Basic EPS USD -0.24\n\n\nMar 10 (Reuters) - Design Therapeutics Q4 operating expenses USD 16.694 million.\n\nQ4 net income USD -13.651 million\nQ4 operating income USD -16.694 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nPLXBFA528:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSGN"],"gpt_icon":0},{"id":"2518324466","title":"Design Therapeutics Q4 Net Income USD -13.651 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2518324466","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518324466?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:07","pubTimestamp":1741604849,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nPLXBFA528:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4539","BK4139","DSGN"],"gpt_icon":0},{"id":"2518423852","title":"Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2518423852","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518423852?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:07","pubTimestamp":1741604820,"startTime":"0","endTime":"0","summary":"Initiated Phase 1 Single Ascending Dose Trial of DT-216P2 in Healthy Volunteers; Friedreich Ataxia (FA) Patient Dosing to Begin in mid-2025 Dosing Complete in DT-168 Phase 1 Healthy Volunteer Trial, w","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/10/3039587/0/en/Design-Therapeutics-Highlights-Progress-Across-Lead-GeneTAC-Programs-and-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013342.USD","LU0868494617.USD","LU0820562030.AUD","LU0868494708.USD","PRGS","PD","LU0820561818.USD","SG9999001440.SGD","LU1035775433.USD","BK4585","LU0823411888.USD","LU0942090050.USD","LU0320765646.SGD","BK4535","LU2756315664.SGD","PK","LU1162221912.USD","LU0823434740.USD","BK4588","LU1674673691.USD","BK4539","LU0943347566.SGD","FA","BK4181","IE00B1XK9C88.USD","BK4566","LU1093756168.USD","BK4533","HD","IE00BKVL7J92.USD","BK4534","BK4023","LU1778281490.HKD","LU1929549753.HKD","LU2756315318.SGD","LU1093756325.SGD","BK4218","LU0234572021.USD","IE00BWXC8680.SGD","BK4097","DSGN","LU1169590202.USD","LU0079474960.USD","LU1496350171.SGD","IE00BZ1G4Q59.USD","LU1914381329.SGD","LU1989772840.SGD","BK4504","BK4505","LENZ"],"gpt_icon":0},{"id":"2516633921","title":"Design Therapeutics to Participate in Leerink’s Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2516633921","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516633921?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:00","pubTimestamp":1741006800,"startTime":"0","endTime":"0","summary":"CARLSBAD, Calif., March 03, 2025  -- Design Therapeutics, Inc. , a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a fireside chat during Leerink’s Global Healthcare Conference on Monday, March 10, 2025, at 1:40 p.m. ET in Miami.A live webcast of the fireside chat will be available here and in the investors section of the company’s website at www.designtx.com. The webcast will be archived for at least 30 days following the presentation.About Design TherapeuticsDesign Therapeutics is a clinical-stage biotechnology company developing a new class of therapies based on its platform of GeneTAC gene targeted chimera small molecules. The company’s GeneTAC molecules are designed to either dial up or dial down the expression of a specific disease-causing gene to address the underlying cause of disease. In addition to its GeneTAC programs, DT-216P2, in development for patients with Friedreic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/design-therapeutics-participate-leerink-global-130000119.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","BK4539","BK4139","HCSG","BK4505","DSGN","BK4137"],"gpt_icon":0},{"id":"2505573769","title":"3 Promising US Penny Stocks With Market Caps Under $900M","url":"https://stock-news.laohu8.com/highlight/detail?id=2505573769","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505573769?lang=en_us&edition=fundamental","pubTime":"2025-01-22 08:07","pubTimestamp":1737504470,"startTime":"0","endTime":"0","summary":"As the U.S. stock market continues to rally following President Trump's return to office, investors are closely watching the impact of new policies on various sectors. In this context, penny stocks remain an intriguing area for those looking for potential growth opportunities. Though often associated with speculative trading, these smaller or newer companies can offer significant returns when they possess strong financial fundamentals. We'll highlight three such penny stocks that stand out due to their financial health and potential for long-term success.Click here to see the full list of 709 stocks from our US Penny Stocks screener.Overview: Navitas Semiconductor Corporation designs, develops, and markets gallium nitride power integrated circuits and related technologies for power conversion and charging, with a market cap of approximately $609 million.Assess Navitas Semiconductor's future earnings estimates with our detailed growth reports.Overview: AbCellera Biologics Inc. focuses o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-promising-us-penny-stocks-000750011.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4539","NVTS","BK4121","BK4505","DSGN","BK4209","PVL","BK4535","BABB","BK4213","ABCL"],"gpt_icon":1},{"id":"2495549449","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2495549449","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495549449?lang=en_us&edition=fundamental","pubTime":"2024-12-30 20:47","pubTimestamp":1735562846,"startTime":"0","endTime":"0","summary":"Repay Holdings  shares slumped 22% pre-bell Monday following a 1.7% loss in the previous session.DallasNews Corporation  shares fell 19%, reversing from Friday's gains.Design Therapeutics  shares decreased 16% after a 3.7% loss on Friday.Chicago Rivet & Machine  shares slid 13% after a 2.5% drop.Septerna  shares were down 13%, adding to Friday's 1.7% loss.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DSGN","BK4111","DALN","BK4106","CVR","LU1861220207.SGD","BK4139","BK4161","BK4539","BK4227","BK7095","CVR.AU","LU1861217088.USD","BK4007","RPAY","BK4505","SEPN"],"gpt_icon":0},{"id":"2493875240","title":"Investors Look to Reverse Last Week's Slide as US Futures Mixed Monday Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2493875240","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493875240?lang=en_us&edition=fundamental","pubTime":"2024-12-23 21:08","pubTimestamp":1734959307,"startTime":"0","endTime":"0","summary":"US stock futures are mixed in Monday's premarket session as investors hope to reverse last week losses during the holiday-shortened week.The Dow Jones Industrial Average futures were down 0.2%, S&P 50","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ISBC","BK4077","BK4007","IE00B19Z4B17.USD","BK4123","BK4211","BK4505","BK4539","IE00B66KJ199.SGD","PBM","IE0031619046.USD","DSGN","BK4516","TRAW","PHIO","BK4139","IE00B7SZL793.SGD","MG","RUM"],"gpt_icon":1},{"id":"2483730002","title":"Design Therapeutics to Participate in Multiple Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2483730002","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483730002?lang=en_us&edition=fundamental","pubTime":"2024-11-13 21:00","pubTimestamp":1731502800,"startTime":"0","endTime":"0","summary":"CARLSBAD, Calif., Nov. 13, 2024  -- Design Therapeutics, Inc. , a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in the following upcoming investor conferences:. Piper Sandler 36th Annual Healthcare ConferenceFireside Chat:Tuesday, December 3, 2024, at 11:30 a.m. ETLocation:New York, NY. Live webcasts of the presentations will be available here and in the investors section of the company’s website at www.designtx.com. The webcasts will be archived for at least 30 days following each presentation.About Design TherapeuticsDesign Therapeutics is a clinical-stage biotechnology company developing a new class of therapies based on its platform of GeneTAC gene targeted chimera small molecules. The company’s GeneTAC molecules are designed to either dial up or dial down the expression of a specific disease-causing gene to address the underlying cause of disease. In addition to its lead GeneTA","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9bghZNWF49L96eb8GM1KLw--~B/aD0zMjk7dz0xMzY5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/3972332133f117588897c236558bb568","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9bghZNWF49L96eb8GM1KLw--~B/aD0zMjk7dz0xMzY5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/3972332133f117588897c236558bb568"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/design-therapeutics-participate-multiple-upcoming-130000568.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4505","LENZ","DSGN","BK4539","BK4139"],"gpt_icon":0},{"id":"2482223512","title":"Cautious Optimism for Design Therapeutics Amid Promising Developments and Financial Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2482223512","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482223512?lang=en_us&edition=fundamental","pubTime":"2024-11-11 14:31","pubTimestamp":1731306700,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst Joseph Schwartz reiterated a Hold rating on Design Therapeutics (DSGN – Research Report) on November 7 and set a price tar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cautious-optimism-for-design-therapeutics-amid-promising-developments-and-financial-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cautious-optimism-for-design-therapeutics-amid-promising-developments-and-financial-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DSGN","BK4539","BK4505","BK4139","LENZ"],"gpt_icon":0},{"id":"2482248514","title":"Design Therapeutics Inc  expected to post a loss of 27 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2482248514","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482248514?lang=en_us&edition=fundamental","pubTime":"2024-11-09 00:03","pubTimestamp":1731081795,"startTime":"0","endTime":"0","summary":"Design Therapeutics Inc  expected to post a loss of27cents a share - Earnings Preview Design Therapeutics Inc DSGN.OQ DSGN.O is expected to show no change in quarterly revenue when it reports  results","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL8N3MF2B9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSGN"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DSGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-10","symbol":"DSGN","fiscalQuarterEnding":"2024/12","expectedEps":-0.28,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741579200000,"reportTimeType":"pre","actualEps":-0.24},{"market":"US","date":"2024-11-07","symbol":"DSGN","fiscalQuarterEnding":"2024/09","expectedEps":-0.26,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.23},{"market":"US","date":"2024-08-05","symbol":"DSGN","fiscalQuarterEnding":"2024/06","expectedEps":-0.25,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722830400000,"reportTimeType":"pre","actualEps":-0.21},{"market":"US","date":"2024-05-08","symbol":"DSGN","fiscalQuarterEnding":"2024/03","expectedEps":-0.28,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"post","actualEps":-0.2},{"market":"US","date":"2024-03-19","symbol":"DSGN","fiscalQuarterEnding":"2023/12","expectedEps":-0.32,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1710820800000,"reportTimeType":"post","actualEps":-0.21}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DSGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DSGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.3333,"hold":0.6667,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6667,"analysts":3,"updateTime":1715054400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DSGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DSGN","date":"2025-04-30","current":-5.025171,"percent":0.706468,"low":-266.429784,"twenty":-31.903293,"median":-7.098516,"eighty":-3.720229,"high":-1.499813,"avg":-23.225631,"sd":35.814819,"marketCap":249188156},"quantilePoints":[{"date":"2021-03-26","current":-266.429784,"twenty":-210.836408,"median":-127.446345,"eighty":-127.446345,"marketCap":2206038609},{"date":"2021-04-01","current":-197.50827,"twenty":-214.41814,"median":-197.50827,"eighty":-141.153339,"marketCap":1635368477},{"date":"2021-04-09","current":-176.59563,"twenty":-198.344776,"median":-196.080899,"eighty":-180.260321,"marketCap":1462211815},{"date":"2021-04-16","current":-156.014936,"twenty":-197.667604,"median":-194.919086,"eighty":-154.315369,"marketCap":1291803671},{"date":"2021-04-23","current":-127.932248,"twenty":-197.242713,"median":-162.554285,"eighty":-132.181165,"marketCap":1059279010},{"date":"2021-04-30","current":-174.139224,"twenty":-196.140649,"median":-157.342723,"eighty":-136.589417,"marketCap":1441872778},{"date":"2021-05-07","current":-186.222083,"twenty":-195.848536,"median":-170.952536,"eighty":-141.767785,"marketCap":1541918850},{"date":"2021-05-14","current":-96.369524,"twenty":-195.237755,"median":-157.342723,"eighty":-127.543526,"marketCap":1265428224},{"date":"2021-05-21","current":-114.100846,"twenty":-193.179685,"median":-153.62492,"eighty":-115.014659,"marketCap":1498258211},{"date":"2021-05-28","current":-109.825208,"twenty":-185.74408,"median":-150.6374,"eighty":-111.52708,"marketCap":1442114810},{"date":"2021-06-04","current":-109.950962,"twenty":-183.832067,"median":-141.741229,"eighty":-110.034798,"marketCap":1443766086},{"date":"2021-06-11","current":-113.555912,"twenty":-182.371502,"median":-128.861698,"eighty":-110.579733,"marketCap":1491102679},{"date":"2021-06-18","current":-107.813143,"twenty":-179.516761,"median":-127.446345,"eighty":-110.579733,"marketCap":1415694386},{"date":"2021-06-25","current":-98.423507,"twenty":-176.59563,"median":-117.223738,"eighty":-109.489864,"marketCap":1292399074},{"date":"2021-07-02","current":-81.153284,"twenty":-176.462851,"median":-115.567977,"eighty":-105.004636,"marketCap":1065623768},{"date":"2021-07-09","current":-77.757924,"twenty":-174.603949,"median":-114.561944,"eighty":-98.322904,"marketCap":1021039302},{"date":"2021-07-16","current":-74.404483,"twenty":-169.040523,"median":-113.828379,"eighty":-95.841357,"marketCap":977005262},{"date":"2021-07-23","current":-76.668056,"twenty":-165.26961,"median":-113.094814,"eighty":-89.595573,"marketCap":1006728239},{"date":"2021-07-30","current":-64.889093,"twenty":-158.803288,"median":-112.193576,"eighty":-80.013113,"marketCap":852058674},{"date":"2021-08-06","current":-64.134568,"twenty":-156.280493,"median":-110.789323,"eighty":-77.556718,"marketCap":842151015},{"date":"2021-08-13","current":-47.086374,"twenty":-154.315369,"median":-109.99288,"eighty":-75.217692,"marketCap":909944175},{"date":"2021-08-20","current":-42.665788,"twenty":-153.465586,"median":-109.489864,"eighty":-73.733794,"marketCap":824516345},{"date":"2021-08-27","current":-49.681686,"twenty":-152.828248,"median":-106.932865,"eighty":-66.507128,"marketCap":960098579},{"date":"2021-09-03","current":-50.480243,"twenty":-151.049014,"median":-103.747096,"eighty":-64.922627,"marketCap":975530703},{"date":"2021-09-10","current":-48.42681,"twenty":-145.379365,"median":-98.423507,"eighty":-59.380132,"marketCap":935848098},{"date":"2021-09-17","current":-46.116697,"twenty":-141.794341,"median":-96.87254,"eighty":-49.328039,"marketCap":891205167},{"date":"2021-09-24","current":-45.460739,"twenty":-137.87737,"median":-95.573082,"eighty":-48.392586,"marketCap":878528780},{"date":"2021-10-01","current":-42.751347,"twenty":-131.995275,"median":-92.21964,"eighty":-47.063558,"marketCap":826169787},{"date":"2021-10-08","current":-41.83871,"twenty":-128.675808,"median":-83.374939,"eighty":-46.116697,"marketCap":808533074},{"date":"2021-10-15","current":-40.640874,"twenty":-127.640706,"median":-79.686153,"eighty":-45.477851,"marketCap":785384888},{"date":"2021-10-22","current":-42.123909,"twenty":-127.446345,"median":-78.889711,"eighty":-45.021532,"marketCap":814044547},{"date":"2021-10-29","current":-44.719221,"twenty":-126.742046,"median":-76.709974,"eighty":-44.53099,"marketCap":864198950},{"date":"2021-11-05","current":-51.164721,"twenty":-121.710952,"median":-75.284761,"eighty":-44.593734,"marketCap":988758238},{"date":"2021-11-12","current":-39.021081,"twenty":-116.934504,"median":-74.383524,"eighty":-44.308534,"marketCap":1105194080},{"date":"2021-11-19","current":-39.996121,"twenty":-115.752416,"median":-72.727762,"eighty":-43.65828,"marketCap":1132810124},{"date":"2021-11-26","current":-34.672405,"twenty":-115.66858,"median":-68.913222,"eighty":-43.110698,"marketCap":982026524},{"date":"2021-12-03","current":-30.694244,"twenty":-115.517675,"median":-66.167592,"eighty":-42.819795,"marketCap":869353065},{"date":"2021-12-10","current":-34.204386,"twenty":-115.090111,"median":-64.931011,"eighty":-42.021238,"marketCap":968770823},{"date":"2021-12-17","current":-31.903293,"twenty":-114.427806,"median":-64.260322,"eighty":-41.678999,"marketCap":903596959},{"date":"2021-12-23","current":-35.822952,"twenty":-114.201449,"median":-51.891979,"eighty":-41.085785,"marketCap":1014613456},{"date":"2021-12-31","current":-41.751192,"twenty":-113.991859,"median":-50.622843,"eighty":-40.984623,"marketCap":1182519004},{"date":"2022-01-07","current":-35.04292,"twenty":-113.513994,"median":-49.938365,"eighty":-40.646578,"marketCap":992520621},{"date":"2022-01-14","current":-30.908752,"twenty":-113.29602,"median":-48.683489,"eighty":-39.742758,"marketCap":875428594},{"date":"2022-01-21","current":-21.782383,"twenty":-113.094814,"median":-48.42681,"eighty":-39.567103,"marketCap":616942422},{"date":"2022-01-28","current":-24.395488,"twenty":-112.256453,"median":-47.927711,"eighty":-38.74807,"marketCap":690953420},{"date":"2022-02-04","current":-24.844007,"twenty":-112.256453,"median":-47.428613,"eighty":-36.914996,"marketCap":703656801},{"date":"2022-02-11","current":-28.315147,"twenty":-112.130699,"median":-46.872474,"eighty":-36.193467,"marketCap":801969917},{"date":"2022-02-18","current":-26.930591,"twenty":-111.376175,"median":-46.116697,"eighty":-35.140424,"marketCap":762755135},{"date":"2022-02-25","current":-26.384569,"twenty":-110.906693,"median":-45.774458,"eighty":-34.672405,"marketCap":747290150},{"date":"2022-03-04","current":-29.875211,"twenty":-110.621651,"median":-45.474999,"eighty":-34.235588,"marketCap":846155588},{"date":"2022-03-11","current":-26.924006,"twenty":-110.143785,"median":-45.23258,"eighty":-33.798769,"marketCap":956690692},{"date":"2022-03-18","current":-30.685562,"twenty":-109.967729,"median":-44.990161,"eighty":-32.613122,"marketCap":1090350087},{"date":"2022-03-25","current":-25.815829,"twenty":-109.850359,"median":-44.605142,"eighty":-31.220765,"marketCap":917313858},{"date":"2022-04-01","current":-26.736708,"twenty":-109.556933,"median":-44.419762,"eighty":-30.692508,"marketCap":950035452},{"date":"2022-04-08","current":-24.676436,"twenty":-109.221589,"median":-44.205863,"eighty":-29.793308,"marketCap":876827817},{"date":"2022-04-14","current":-23.786774,"twenty":-108.349694,"median":-43.806584,"eighty":-29.251185,"marketCap":845215429},{"date":"2022-04-22","current":-21.195826,"twenty":-106.756809,"median":-43.278965,"eighty":-28.904071,"marketCap":753151281},{"date":"2022-04-29","current":-18.663489,"twenty":-105.423816,"median":-43.036546,"eighty":-28.089583,"marketCap":663169748},{"date":"2022-05-06","current":-17.50679,"twenty":-104.250112,"median":-42.822647,"eighty":-27.285506,"marketCap":622068776},{"date":"2022-05-13","current":-14.044836,"twenty":-102.439254,"median":-42.665788,"eighty":-27.133155,"marketCap":607916686},{"date":"2022-05-20","current":-14.648777,"twenty":-99.681048,"median":-41.92427,"eighty":-26.849087,"marketCap":634057660},{"date":"2022-05-27","current":-16.627647,"twenty":-98.121697,"median":-41.751192,"eighty":-26.443276,"marketCap":719711063},{"date":"2022-06-03","current":-19.287556,"twenty":-97.702517,"median":-41.667591,"eighty":-25.832717,"marketCap":834842585},{"date":"2022-06-10","current":-17.154489,"twenty":-96.973144,"median":-41.420536,"eighty":-25.210077,"marketCap":742514891},{"date":"2022-06-17","current":-18.131074,"twenty":-96.185085,"median":-40.990661,"eighty":-25.044788,"marketCap":784785402},{"date":"2022-06-24","current":-19.595952,"twenty":-95.841357,"median":-40.783473,"eighty":-24.855707,"marketCap":848191168},{"date":"2022-07-01","current":-18.105374,"twenty":-95.380259,"median":-40.655134,"eighty":-24.539794,"marketCap":783673020},{"date":"2022-07-08","current":-21.908916,"twenty":-94.608968,"median":-39.96687,"eighty":-24.200481,"marketCap":948305535},{"date":"2022-07-15","current":-23.695039,"twenty":-93.435263,"median":-39.703609,"eighty":-23.412179,"marketCap":1025616074},{"date":"2022-07-22","current":-25.185616,"twenty":-91.004018,"median":-39.586604,"eighty":-23.430199,"marketCap":1090134222},{"date":"2022-07-29","current":-25.211316,"twenty":-83.961791,"median":-38.901159,"eighty":-23.515142,"marketCap":1091246604},{"date":"2022-08-05","current":-28.179621,"twenty":-83.374939,"median":-38.670067,"eighty":-23.695039,"marketCap":1219726709},{"date":"2022-08-12","current":-27.381487,"twenty":-81.153284,"median":-37.110004,"eighty":-23.695039,"marketCap":1386790181},{"date":"2022-08-19","current":-23.982178,"twenty":-80.231087,"median":-36.719988,"eighty":-23.786774,"marketCap":1214625389},{"date":"2022-08-26","current":-22.299026,"twenty":-79.141219,"median":-36.193467,"eighty":-23.56414,"marketCap":1129378745},{"date":"2022-09-02","current":-23.729155,"twenty":-78.889711,"median":-35.715698,"eighty":-23.430199,"marketCap":1201810534},{"date":"2022-09-09","current":-27.08446,"twenty":-78.889711,"median":-35.091672,"eighty":-23.498153,"marketCap":1371746655},{"date":"2022-09-16","current":-23.971177,"twenty":-77.984281,"median":-34.672405,"eighty":-23.55434,"marketCap":1214068222},{"date":"2022-09-23","current":-15.500408,"twenty":-76.953098,"median":-34.477397,"eighty":-23.151365,"marketCap":785049162},{"date":"2022-09-30","current":-18.393671,"twenty":-76.684823,"median":-34.243388,"eighty":-22.844603,"marketCap":931584243},{"date":"2022-10-07","current":-17.249567,"twenty":-75.86323,"median":-33.999628,"eighty":-22.293133,"marketCap":873638812},{"date":"2022-10-14","current":-17.359577,"twenty":-75.360213,"median":-33.151343,"eighty":-22.005731,"marketCap":879210488},{"date":"2022-10-21","current":-17.194562,"twenty":-75.016486,"median":-32.595571,"eighty":-21.84249,"marketCap":870852974},{"date":"2022-10-28","current":-17.711609,"twenty":-74.51347,"median":-31.454775,"eighty":-21.303916,"marketCap":897039852},{"date":"2022-11-04","current":-15.136782,"twenty":-74.370949,"median":-30.879501,"eighty":-20.900276,"marketCap":863296062},{"date":"2022-11-11","current":-14.931172,"twenty":-74.060755,"median":-30.694244,"eighty":-19.723275,"marketCap":851569531},{"date":"2022-11-18","current":-14.745144,"twenty":-72.97927,"median":-30.192539,"eighty":-19.41378,"marketCap":840959812},{"date":"2022-11-25","current":-14.422043,"twenty":-71.721729,"median":-29.670452,"eighty":-19.268993,"marketCap":822532406},{"date":"2022-12-02","current":-13.707305,"twenty":-69.76835,"median":-29.329188,"eighty":-18.888157,"marketCap":781768750},{"date":"2022-12-09","current":-7.695673,"twenty":-67.479626,"median":-29.031924,"eighty":-18.586365,"marketCap":438907312},{"date":"2022-12-16","current":-8.576857,"twenty":-66.473593,"median":-28.822168,"eighty":-18.277562,"marketCap":489163875},{"date":"2022-12-23","current":-9.330759,"twenty":-66.113099,"median":-28.324897,"eighty":-18.023135,"marketCap":532161156},{"date":"2022-12-30","current":-10.045497,"twenty":-65.844823,"median":-28.154588,"eighty":-17.973069,"marketCap":572924812},{"date":"2023-01-06","current":-9.183895,"twenty":-65.601699,"median":-27.633426,"eighty":-17.716009,"marketCap":523785062},{"date":"2023-01-13","current":-8.811839,"twenty":-64.922627,"median":-27.423465,"eighty":-17.593425,"marketCap":502565625},{"date":"2023-01-20","current":-8.733512,"twenty":-64.889093,"median":-27.301106,"eighty":-17.524592,"marketCap":498098375},{"date":"2023-01-27","current":-8.097101,"twenty":-64.386076,"median":-27.223103,"eighty":-17.359577,"marketCap":461801968},{"date":"2023-02-03","current":-7.842537,"twenty":-64.134568,"median":-27.08446,"eighty":-17.183561,"marketCap":447283406},{"date":"2023-02-10","current":-6.892816,"twenty":-52.248478,"median":-26.981927,"eighty":-17.051549,"marketCap":393118000},{"date":"2023-02-17","current":-7.475377,"twenty":-51.53548,"median":-26.856091,"eighty":-16.886534,"marketCap":426343171},{"date":"2023-02-24","current":-6.726371,"twenty":-51.238873,"median":-26.674276,"eighty":-16.69122,"marketCap":383625093},{"date":"2023-03-03","current":-6.951562,"twenty":-50.731219,"median":-26.498709,"eighty":-16.159906,"marketCap":396468437},{"date":"2023-03-10","current":-6.354315,"twenty":-50.508763,"median":-26.424546,"eighty":-15.47143,"marketCap":362405656},{"date":"2023-03-17","current":-5.721291,"twenty":-50.252084,"median":-25.875202,"eighty":-15.276524,"marketCap":362203462},{"date":"2023-03-24","current":-5.129737,"twenty":-49.784358,"median":-25.72218,"eighty":-15.032998,"marketCap":324753412},{"date":"2023-03-31","current":-5.094421,"twenty":-48.974392,"median":-25.632328,"eighty":-14.62497,"marketCap":322517588},{"date":"2023-04-06","current":-4.807473,"twenty":-48.729121,"median":-25.599325,"eighty":-14.343716,"marketCap":304351520},{"date":"2023-04-14","current":-4.679638,"twenty":-48.597929,"median":-25.445311,"eighty":-14.163054,"marketCap":296258514},{"date":"2023-04-21","current":-4.935694,"twenty":-48.472442,"median":-25.311858,"eighty":-14.01165,"marketCap":312468886},{"date":"2023-04-28","current":-5.71269,"twenty":-48.375474,"median":-25.214522,"eighty":-13.724787,"marketCap":361658979},{"date":"2023-05-05","current":-6.692765,"twenty":-48.101683,"median":-25.201067,"eighty":-13.437076,"marketCap":423705574},{"date":"2023-05-12","current":-5.135342,"twenty":-47.924859,"median":-25.156019,"eighty":-12.610371,"marketCap":356069196},{"date":"2023-05-19","current":-5.629297,"twenty":-47.673884,"median":-24.996935,"eighty":-9.479581,"marketCap":390318535},{"date":"2023-05-26","current":-5.605102,"twenty":-47.462837,"median":-24.902509,"eighty":-9.144731,"marketCap":388640948},{"date":"2023-06-02","current":-4.379238,"twenty":-47.291717,"median":-24.785251,"eighty":-8.913665,"marketCap":303643216},{"date":"2023-06-09","current":-4.508276,"twenty":-47.063558,"median":-24.686839,"eighty":-8.782467,"marketCap":312590345},{"date":"2023-06-16","current":-4.419562,"twenty":-46.903846,"median":-24.512493,"eighty":-8.694348,"marketCap":306439194},{"date":"2023-06-23","current":-4.508276,"twenty":-46.698503,"median":-24.363229,"eighty":-8.482864,"marketCap":312590345},{"date":"2023-06-30","current":-4.693769,"twenty":-46.630055,"median":-24.270625,"eighty":-8.312502,"marketCap":325451845},{"date":"2023-07-07","current":-5.242182,"twenty":-46.219369,"median":-24.200481,"eighty":-8.204801,"marketCap":363477146},{"date":"2023-07-14","current":-5.564777,"twenty":-46.116697,"median":-24.086688,"eighty":-8.010941,"marketCap":385844970},{"date":"2023-07-21","current":-5.758335,"twenty":-45.842906,"median":-23.971177,"eighty":-7.801415,"marketCap":399265665},{"date":"2023-07-28","current":-5.693816,"twenty":-45.614747,"median":-23.757964,"eighty":-7.693715,"marketCap":394792100},{"date":"2023-08-04","current":-6.137385,"twenty":-45.506371,"median":-23.586142,"eighty":-7.022056,"marketCap":425547859},{"date":"2023-08-11","current":-6.048671,"twenty":-45.466443,"median":-23.539641,"eighty":-6.920231,"marketCap":419396707},{"date":"2023-08-18","current":-1.597791,"twenty":-45.301028,"median":-23.412179,"eighty":-6.881067,"marketCap":118675901},{"date":"2023-08-25","current":-1.545033,"twenty":-45.238284,"median":-23.060996,"eighty":-6.818405,"marketCap":114757357},{"date":"2023-09-01","current":-1.869114,"twenty":-45.23258,"median":-22.932929,"eighty":-6.723182,"marketCap":138828413},{"date":"2023-09-08","current":-1.982165,"twenty":-45.181244,"median":-22.321028,"eighty":-6.68217,"marketCap":147225293},{"date":"2023-09-15","current":-2.019849,"twenty":-44.958789,"median":-22.291218,"eighty":-6.567759,"marketCap":150024253},{"date":"2023-09-22","current":-1.812588,"twenty":-44.764853,"median":-22.113896,"eighty":-6.269649,"marketCap":134629973},{"date":"2023-09-29","current":-1.820125,"twenty":-44.650774,"median":-21.978378,"eighty":-6.208739,"marketCap":135189765},{"date":"2023-10-06","current":-1.778673,"twenty":-44.58803,"median":-21.857517,"eighty":-6.16158,"marketCap":132110909},{"date":"2023-10-13","current":-1.635474,"twenty":-44.508174,"median":-21.601439,"eighty":-6.058349,"marketCap":121474861},{"date":"2023-10-20","current":-1.643011,"twenty":-44.411206,"median":-21.195826,"eighty":-5.916407,"marketCap":122034653},{"date":"2023-10-27","current":-1.560107,"twenty":-44.376982,"median":-21.039745,"eighty":-5.88928,"marketCap":115876941},{"date":"2023-11-03","current":-1.57518,"twenty":-44.205863,"median":-20.897841,"eighty":-5.806724,"marketCap":116996525},{"date":"2023-11-10","current":-1.499813,"twenty":-44.205863,"median":-19.91596,"eighty":-5.721291,"marketCap":111398606},{"date":"2023-11-17","current":-1.702607,"twenty":-44.120303,"median":-19.653361,"eighty":-5.669621,"marketCap":123200631},{"date":"2023-11-24","current":-1.718085,"twenty":-43.869328,"median":-19.507566,"eighty":-5.605102,"marketCap":124320637},{"date":"2023-12-01","current":-1.857389,"twenty":-43.509977,"median":-19.287556,"eighty":-5.561551,"marketCap":134400688},{"date":"2023-12-08","current":-1.857389,"twenty":-43.390193,"median":-19.159059,"eighty":-5.507625,"marketCap":134400688},{"date":"2023-12-15","current":-1.996693,"twenty":-43.219074,"median":-18.921719,"eighty":-5.433509,"marketCap":144480740},{"date":"2023-12-22","current":-1.965737,"twenty":-43.087882,"median":-18.799264,"eighty":-5.343671,"marketCap":142240728},{"date":"2023-12-27","current":-2.089563,"twenty":-43.059362,"median":-18.712101,"eighty":-5.287269,"marketCap":151200774},{"date":"2024-01-05","current":-1.981215,"twenty":-43.04225,"median":-18.470678,"eighty":-5.23573,"marketCap":143360734},{"date":"2024-01-12","current":-1.872868,"twenty":-42.945283,"median":-18.384445,"eighty":-5.127971,"marketCap":135520694},{"date":"2024-01-19","current":-1.803215,"twenty":-42.871131,"median":-18.118224,"eighty":-5.094421,"marketCap":130480668},{"date":"2024-01-26","current":-1.826433,"twenty":-42.819795,"median":-18.028275,"eighty":-4.997082,"marketCap":132160677},{"date":"2024-02-02","current":-1.865128,"twenty":-42.774163,"median":-17.98818,"eighty":-4.874809,"marketCap":134960691},{"date":"2024-02-09","current":-1.772259,"twenty":-42.700012,"median":-17.771279,"eighty":-4.788954,"marketCap":128240657},{"date":"2024-02-16","current":-1.965737,"twenty":-42.340661,"median":-17.69647,"eighty":-4.679638,"marketCap":142240728},{"date":"2024-02-23","current":-2.182432,"twenty":-42.055461,"median":-17.629102,"eighty":-4.609731,"marketCap":157920809},{"date":"2024-03-01","current":-2.151476,"twenty":-41.929974,"median":-17.535593,"eighty":-4.582513,"marketCap":155680797},{"date":"2024-03-08","current":-2.20565,"twenty":-41.872934,"median":-17.515691,"eighty":-4.52118,"marketCap":159600817},{"date":"2024-03-15","current":-1.919302,"twenty":-41.803703,"median":-17.359577,"eighty":-4.450209,"marketCap":138880711},{"date":"2024-03-22","current":-2.754499,"twenty":-41.72916,"median":-17.259852,"eighty":-4.389842,"marketCap":184171323},{"date":"2024-03-28","current":-3.303709,"twenty":-41.690407,"median":-17.189062,"eighty":-4.322784,"marketCap":220892599},{"date":"2024-04-05","current":-3.007981,"twenty":-41.637509,"median":-17.154489,"eighty":-3.276671,"marketCap":201119604},{"date":"2024-04-12","current":-3.185418,"twenty":-41.505482,"median":-17.040548,"eighty":-3.178658,"marketCap":212983401},{"date":"2024-04-19","current":-3.16007,"twenty":-41.443422,"median":-16.996544,"eighty":-3.16345,"marketCap":211288573},{"date":"2024-04-26","current":-3.177012,"twenty":-41.30824,"median":-16.75806,"eighty":-3.15331,"marketCap":212421346},{"date":"2024-05-03","current":-3.084067,"twenty":-41.007439,"median":-16.688516,"eighty":-3.126272,"marketCap":206206892},{"date":"2024-05-10","current":-4.592936,"twenty":-40.989151,"median":-16.330983,"eighty":-3.126272,"marketCap":269481336},{"date":"2024-05-17","current":-4.332959,"twenty":-40.943185,"median":-16.036556,"eighty":-3.12966,"marketCap":254227675},{"date":"2024-05-24","current":-3.880405,"twenty":-40.774209,"median":-15.427962,"eighty":-3.143214,"marketCap":227675007},{"date":"2024-05-31","current":-3.793746,"twenty":-40.737151,"median":-15.329679,"eighty":-3.143214,"marketCap":222590453},{"date":"2024-06-07","current":-3.938178,"twenty":-40.669394,"median":-15.166154,"eighty":-3.15162,"marketCap":231064709},{"date":"2024-06-14","current":-3.6782,"twenty":-40.646578,"median":-15.136782,"eighty":-3.15838,"marketCap":215811048},{"date":"2024-06-21","current":-3.187132,"twenty":-40.254022,"median":-14.931172,"eighty":-3.16007,"marketCap":186998579},{"date":"2024-06-28","current":-3.225647,"twenty":-39.996121,"median":-14.745144,"eighty":-3.16007,"marketCap":189258380},{"date":"2024-07-05","current":-3.071586,"twenty":-39.949319,"median":-14.648777,"eighty":-3.149939,"marketCap":180219174},{"date":"2024-07-12","current":-4.08261,"twenty":-39.907008,"median":-14.426939,"eighty":-3.15838,"marketCap":239538965},{"date":"2024-07-15","current":-4.198155,"twenty":-39.899356,"median":-14.422043,"eighty":-3.16007,"marketCap":246318370},{"date":"2024-08-02","current":-4.862542,"twenty":-39.860207,"median":-14.324134,"eighty":-3.16007,"marketCap":285299946},{"date":"2024-08-09","current":-4.549453,"twenty":-39.697127,"median":-14.211884,"eighty":-3.16345,"marketCap":229879331},{"date":"2024-08-16","current":-4.807181,"twenty":-39.658179,"median":-14.113498,"eighty":-3.176968,"marketCap":242902052},{"date":"2024-08-23","current":-5.501925,"twenty":-39.598305,"median":-14.044836,"eighty":-3.176977,"marketCap":278006777},{"date":"2024-08-30","current":-5.277814,"twenty":-39.457899,"median":-13.863961,"eighty":-3.178693,"marketCap":266682672},{"date":"2024-09-06","current":-5.277814,"twenty":-39.021081,"median":-13.721873,"eighty":-3.185418,"marketCap":266682672},{"date":"2024-09-13","current":-6.544041,"twenty":-38.901159,"median":-13.668142,"eighty":-3.187132,"marketCap":330663866},{"date":"2024-09-20","current":-6.566452,"twenty":-38.806572,"median":-13.300982,"eighty":-3.193911,"marketCap":331796276},{"date":"2024-09-27","current":-6.073408,"twenty":-38.74807,"median":-12.734156,"eighty":-3.202317,"marketCap":306883245},{"date":"2024-10-04","current":-5.28902,"twenty":-38.592064,"median":-10.065078,"eighty":-3.210766,"marketCap":267248878},{"date":"2024-10-11","current":-5.232992,"twenty":-38.436057,"median":-9.35034,"eighty":-3.210766,"marketCap":264417851},{"date":"2024-10-18","current":-6.745741,"twenty":-37.110004,"median":-9.242641,"eighty":-3.225647,"marketCap":340855560},{"date":"2024-10-25","current":-5.994969,"twenty":-36.914996,"median":-8.997867,"eighty":-3.225647,"marketCap":302919808},{"date":"2024-10-31","current":-6.241491,"twenty":-36.883794,"median":-8.890167,"eighty":-3.261059,"marketCap":315376324},{"date":"2024-11-08","current":-6.861442,"twenty":-36.626384,"median":-8.826526,"eighty":-3.28343,"marketCap":327832839},{"date":"2024-11-15","current":-7.134068,"twenty":-36.563982,"median":-8.762885,"eighty":-3.2918,"marketCap":340858642},{"date":"2024-11-22","current":-6.600791,"twenty":-36.26757,"median":-8.694348,"eighty":-3.301577,"marketCap":315379176},{"date":"2024-11-29","current":-7.110367,"twenty":-36.04136,"median":-8.635603,"eighty":-3.318918,"marketCap":339726222},{"date":"2024-12-06","current":-7.323678,"twenty":-35.869754,"median":-8.469157,"eighty":-3.35367,"marketCap":349918008},{"date":"2024-12-13","current":-7.276275,"twenty":-35.694247,"median":-8.351665,"eighty":-3.370079,"marketCap":347653167},{"date":"2024-12-20","current":-7.098516,"twenty":-35.327632,"median":-8.283129,"eighty":-3.386023,"marketCap":339160011},{"date":"2024-12-27","current":-7.691047,"twenty":-35.101422,"median":-8.204801,"eighty":-3.400032,"marketCap":367470530},{"date":"2025-01-03","current":-7.311827,"twenty":-34.988318,"median":-8.176922,"eighty":-3.4058,"marketCap":349351798},{"date":"2025-01-10","current":-6.014185,"twenty":-34.769909,"median":-8.097101,"eighty":-3.408594,"marketCap":287351762},{"date":"2025-01-17","current":-5.61719,"twenty":-34.672405,"median":-7.916476,"eighty":-3.485624,"marketCap":268383715},{"date":"2025-01-24","current":-6.067513,"twenty":-34.672405,"median":-7.868298,"eighty":-3.554952,"marketCap":289899709},{"date":"2025-01-31","current":-5.889754,"twenty":-34.531999,"median":-7.833254,"eighty":-3.618502,"marketCap":281406553},{"date":"2025-02-07","current":-5.23797,"twenty":-34.465696,"median":-7.778895,"eighty":-3.630056,"marketCap":250264983},{"date":"2025-02-14","current":-4.704693,"twenty":-34.28629,"median":-7.714748,"eighty":-3.653166,"marketCap":224785516},{"date":"2025-02-21","current":-5.937156,"twenty":-34.243388,"median":-7.691047,"eighty":-3.670497,"marketCap":283671395},{"date":"2025-02-28","current":-5.546086,"twenty":-34.219987,"median":-7.584392,"eighty":-3.6782,"marketCap":264986453},{"date":"2025-03-07","current":-6.067513,"twenty":-34.134183,"median":-7.525138,"eighty":-3.695532,"marketCap":289899709},{"date":"2025-03-14","current":-5.402917,"twenty":-33.982077,"median":-7.464706,"eighty":-3.707087,"marketCap":267919840},{"date":"2025-03-21","current":-5.311342,"twenty":-33.57256,"median":-7.406632,"eighty":-3.759082,"marketCap":263378825},{"date":"2025-03-28","current":-4.796233,"twenty":-33.229346,"median":-7.365155,"eighty":-3.845741,"marketCap":237835620},{"date":"2025-04-04","current":-4.029294,"twenty":-32.847131,"median":-7.311827,"eighty":-3.89196,"marketCap":199804626},{"date":"2025-04-11","current":-3.193673,"twenty":-32.632622,"median":-7.282201,"eighty":-3.707087,"marketCap":158367871},{"date":"2025-04-17","current":-3.869038,"twenty":-32.601421,"median":-7.122217,"eighty":-3.707087,"marketCap":191857851},{"date":"2025-04-25","current":-4.853468,"twenty":-32.301109,"median":-7.108217,"eighty":-3.712344,"marketCap":240673754},{"date":"2025-04-30","current":-5.025171,"twenty":-31.903293,"median":-7.098516,"eighty":-3.720229,"marketCap":249188156}],"updateTime":1746118645434}}}